DK275788A - Fibrinolytiske proteiner - Google Patents

Fibrinolytiske proteiner

Info

Publication number
DK275788A
DK275788A DK275788A DK275788A DK275788A DK 275788 A DK275788 A DK 275788A DK 275788 A DK275788 A DK 275788A DK 275788 A DK275788 A DK 275788A DK 275788 A DK275788 A DK 275788A
Authority
DK
Denmark
Prior art keywords
fibrinolytic proteins
fibrinolytic
proteins
Prior art date
Application number
DK275788A
Other languages
Danish (da)
English (en)
Other versions
DK275788D0 (da
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of DK275788D0 publication Critical patent/DK275788D0/da
Publication of DK275788A publication Critical patent/DK275788A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK275788A 1987-05-22 1988-05-20 Fibrinolytiske proteiner DK275788A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5341187A 1987-05-22 1987-05-22

Publications (2)

Publication Number Publication Date
DK275788D0 DK275788D0 (da) 1988-05-20
DK275788A true DK275788A (da) 1989-02-03

Family

ID=21984041

Family Applications (1)

Application Number Title Priority Date Filing Date
DK275788A DK275788A (da) 1987-05-22 1988-05-20 Fibrinolytiske proteiner

Country Status (7)

Country Link
EP (1) EP0292009A1 (fi)
JP (1) JPS6463379A (fi)
KR (1) KR880013978A (fi)
AU (1) AU626147B2 (fi)
DK (1) DK275788A (fi)
FI (1) FI882407A (fi)
NO (1) NO882226L (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079159A (en) * 1983-12-27 1992-01-07 Genetics Institute, Inc. Method for making tissue plasminogen activator
US5756093A (en) * 1985-04-22 1998-05-26 Genentech, Inc. Tissue plasminogen activator variants
US5714372A (en) * 1985-04-22 1998-02-03 Genentech, Inc. Tissue plasminogen activator variants
US5736134A (en) * 1985-04-22 1998-04-07 Genentech, In.C Tissue plasminogen activator variants
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5550042A (en) * 1989-03-06 1996-08-27 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
DE69033699T2 (de) * 1989-03-06 2001-05-23 The Board Of Regents Of The University Of Texas System, Austin Gegenüber eigenen inhibitoren resistente t-pa mutanten
US5866413A (en) * 1989-03-06 1999-02-02 Board Of Regents Of The University Of Texas System Pai-1 mutants
US5190756A (en) * 1989-12-01 1993-03-02 Genentech, Inc. Methods and materials for expression of human plasminogen variant
US5087572A (en) * 1989-12-01 1992-02-11 Genentech, Inc. Dna encoding human plasminogen modified at the cleavage site
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
EP0618964A4 (en) * 1991-12-16 1995-12-06 Genentech Inc Novel tissue plasminogen activator variants.
ATE145669T1 (de) * 1991-12-16 1996-12-15 Genentech Inc T-pa substitutionsvarianten mit verbesserter fibrinspezifität
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
WO1997038087A2 (en) 1996-04-05 1997-10-16 Chiron Corporation Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
EP1636356A1 (en) * 2003-06-11 2006-03-22 Schering Aktiengesellschaft Novel modified corin molecules having substitute activation sequences and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125254A1 (en) * 1982-10-28 1984-11-21 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
DK175327B1 (da) * 1984-10-01 2004-08-23 Integrated Genetics Inc Replicerbar ekspressionsvektor og rekombinant DNA-molekyle, som indkoder aktiv human livmodervævsplasminogen-aktivator, pattedyrscelle transformeret med vektoren og fremgangsmåde til fremstilling af aktiv human vævsplasminogen-aktivator (TPA)
EP0199574B1 (en) * 1985-04-22 1991-10-23 Genentech, Inc. Human tissue plasminogen activator mutants, methods and intermediates therefor, and compositions using such mutants
GB8513358D0 (en) * 1985-05-28 1985-07-03 Wellcome Found Formulation
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
AU605124B2 (en) * 1985-12-23 1991-01-10 Behringwerke Aktiengesellschaft Novel peptide plasminogen activators
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
JP2527454B2 (ja) * 1986-01-31 1996-08-21 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新しい血栓溶解タンパク質
GB8608020D0 (en) * 1986-04-02 1986-05-08 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
AU1652888A (en) 1988-11-24
NO882226D0 (no) 1988-05-20
KR880013978A (ko) 1988-12-22
NO882226L (no) 1988-11-23
AU626147B2 (en) 1992-07-23
JPS6463379A (en) 1989-03-09
EP0292009A1 (en) 1988-11-23
FI882407A0 (fi) 1988-05-20
FI882407A (fi) 1988-11-23
DK275788D0 (da) 1988-05-20

Similar Documents

Publication Publication Date Title
DK97790D0 (da) Renin-inhiberende peptider
ATA30988A (de) Alpinski
DK275788A (da) Fibrinolytiske proteiner
ATA174488A (de) Alpinski
ATA174288A (de) Alpinski
ATA224788A (de) Calcitoninsuppositorien
DK353788A (da) Polypeptidderivater
KR890701123A (ko) 신규의 혈전붕괴 단백질
DK395288D0 (da) Proteiner
DK359888A (da) Fibrinolytisk enzym
DK492588A (da) Merozoit-antigen polypeptider
ATA48687A (de) Guellefass
AT389045B (de) Paraocclusaler loeffel
KR890700720A (ko) 블럭
ATA294988A (de) Haecksler
DK596888A (da) Rekombinant lymfotoksin
AT388649B (de) Sportschuh
ATA162787A (de) Hoergeraet
DK624089D0 (da) Polypeptidforbindelser
DK638788D0 (da) Praeparater
DK101587D0 (da) Peptider
SE8703661D0 (sv) Surfactant-protein ii
DK341687D0 (da) Polypeptider
BR6701551U (pt) Metro-esquadro-profissional
BR8700074A (pt) Diagramador

Legal Events

Date Code Title Description
ATS Application withdrawn